SUBJECT INDEX 



423 



heterotypic psitt.-lgr. ven. viruses, 

 interference among, 164 



inactivated psitt.-lgr. ven. viruses, 

 interference among, 171 

 Psittacosis virus, 2, 3-4, 10, 13, 51 , 65 



antibiotics and, 75 



chemotherapy and, 75 



deoxyribonucleic acid and, 3, 4, 12 



elementary bodies and, 73-75 



fluorescent antibody staining and, 75 



hemagglutination and, 22, 44 



lag period, recoverable infective virus 

 and, 119-120, 126 



recombination and, 302 



ribonucleic acid and, 3, 4 



tissue culture stages and, 72-73 



vaccinia virus and, 4, 8 

 Pterolocera amplicornis, nuclear poly- 

 hedral virus and, 375 

 Pyknosis, cell surface bubbling and, 69 

 Pyrrole-2-carboxylic acid 



bovine submaxillary gland mucoprotein 

 and, 54 



chemical synthesis of, 54, 55 



Q phase, influenza virus and, 2C8 



RDE, see Receptor-destroying enzyme 



RNA, see Ribonucleic acid 



R phase, influenza virus and, 268 



Rabbit 



corneal cells 



herpesvirus and, 81 

 vaccinia virus and, 76 

 Rabbit fibroma virus, 335-336, cell 



infection and, 67 

 Rabbit papillomatosis virus 



papilloma-to-carcinoma sequence and, 

 331-334 



transmission of, 327-331 

 Rabbitpox virus, 4 



hemagglutination and, 45 



recombination and, 299-301 

 Rabies virus, 7, 65, 235 



attenuation of, 226 



autointerference and, 168 



intracellular soluble antigens and, 132 



fibroblasts, tissue culture and, 72 

 Rat 



malignant cells, lymphopathia veneria 

 virus and, 73 



Receptor-destroying enzyme, 31 



N-acetylneuraminic acid, human eryth- 

 rocytes and, 55-56 

 6-a-D-N-acetylneuraminyl-N-acetyl- 



galactosamine and, 57 

 bovine submaxillary gland mucoprotein 



and, 56 

 Chu inhibitor and, 35-36 

 Clostridium welchii and, 32 

 host protection and, 159, 188 

 indicator viruses and, 34 

 mucoid inhibitors and, 37 

 siadyl-lactose and, 58 

 urine mucoprotein and, 56 

 Vibrio cholerae and, 29, 30, 32-33, 41, 52, 



53, 55, 58, 121, 122, 123, 124, 125, 128, 



135, 140, 210, 214 

 viral eclipse phase and, 16, 17 

 Receptor-destroying enzyme gradient, 58- 



59 

 mumps virus and, 33 

 Receptor destruction, elution and, 29 

 Receptor gradient 



BEL influenza virus and, 29 

 indicator viruses and, 34 

 influenza A virus and, 230-231 

 influenza B virus and, 29 

 LEE influenza virus and, 29 

 MEL influenza virus and, 29 

 MIL influenza virus and, 29 

 mumps virus and, 29 

 Newcastle disease virus and, 29 

 swine influenza virus and, 29 

 WS influenza A virus and, 29 

 Receptors 

 myxoviruses 



chemistry of, 51-59 



fowl plague and, 51 



influenza A, B, C and D and, 51, 52 



Newcastle disease and, 51 

 Recom bination 

 experiments 



inactive "parent" and, 281 



principles of, 280-282 



tissue culture and, 280-281 



virulence and, 281-282 

 influenza viruses and, 282-299 

 interpretation, 293-294 



genetic aspects and, 294 



genetic loci and, 297 



